Jagsonpal Pharmaceuticals Share Price

NSE: JAGSNPHARM

₹ 223.50

+₹5.68 (2.61%)

Last updated 24 Jul, 2026, 15:29 IST

Jagsonpal Pharmaceuticals Share Price Today

As of 25 Jul 2026, Jagsonpal Pharmaceuticals share price is ₹223.50. The stock opened at ₹217.30, compared to its previous close of ₹217.82. During today's trading session, Jagsonpal Pharmaceuticals share price moved in the range of ₹214.24 to ₹223.85, with an average price of ₹219.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹155.00 and a high of ₹301.65. On the performance front, Jagsonpal Pharmaceuticals share price has increased by 35.35% over the last six months and is down 12.44% on a year-on-year basis.

₹214.24

2.61% up today

₹223.85

1D LOW

1D HIGH

Stock Performance

OutperformingBeat Nifty by 9.72 % in last 3 month

Shareholding Pattern

PromoterPromoter increased stake by 1.71%

Shareholding Pattern

DIIDII increased stake by 177.09%

Shareholding Pattern

FIIFII decreased stake by 5.84%

Jagsonpal Pharmaceuticals Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹4,24,437-₹75,563 (-15.11%)

3 Year

₹5,83,856+₹83,856 (+16.77%)

5 Year

₹15,57,491+₹10,57,491 (+211.50%)

₹174.26₹261.38

Circuit Low

Circuit High

₹155.00₹301.65

52-Week Low

52-Week High

Circuit

₹174.26

₹261.38

52-week

₹155.00

₹301.65

Mkt Cap Cr

1,436.27

P/E

34.00

P/B

5.30

ROE

15.60%

D/E

0.03

ROCE

20.59%

Div. Yield

1.86%

EPS(TTM)

6.40

Turnover

1.00

EV/EBITDA

19.68

Net Margin

0.00%

Op. Margin

0.00%

ROA

13.60%

Quick Ratio

0.00

Curr. Ratio

5.35

Mkt Cap Cr

1,436.27

P/E

34.00

P/B

5.30

ROE

15.60%

D/E

0.03

ROCE

20.59%

Div. Yield

1.86%

EPS(TTM)

6.40

Turnover

1.00

EV/EBITDA

19.68

Net Margin

0.00%

Op. Margin

0.00%

ROA

13.60%

Quick Ratio

0.00

Curr. Ratio

5.35

Based on fundamentals, this stock's

Performance

Very Poor

Jagsonpal Pharma has not beaten FD return of 7%

Valuation

Overvalued

Jagsonpal Pharma appears overvalued compared to its peers

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,65,711.00	36.73	5.05	14.85%	0.55	18.72%	18.85	0.91%	0.56	10.90
Divis Laboratories	1,93,860.00	61.36	9.40	16.19%	0.00	21.00%	9.43	0.50%	0.58	98.19
Torrent Pharmaceuticals	1,92,687.00	66.03	17.03	26.76%	1.05	18.30%	16.90	0.90%	0.49	64.75
Cipla	1,12,593.00	33.55	3.27	11.27%	0.00	14.95%	423.36	0.93%	0.44	43.52
Zydus Lifesciences	1,11,082.00	17.39	3.23	19.69%	0.35	20.30%	3.70	0.11%	0.39	35.38
Lupin	1,09,553.00	19.83	4.71	27.01%	0.03	27.44%	3.51	0.78%	0.61	129.18
Mankind Pharma	1,05,607.00	1.05	0.12	12.65%	0.42	12.97%	5.05	0.05%	0.54	49.37
Dr. Reddy's Laboratories	97,364.90	30.58	2.56	11.07%	0.18	12.54%	377.96	0.69%	0.41	38.68
Aurobindo Pharma	88,508.40	25.27	2.34	9.25%	0.19	11.76%	391.14	0.26%	0.48	41.58
Laurus Labs	84,727.30	60.26	10.10	18.21%	0.40	16.70%	97.21	0.12%	0.64	13.72

Jagsonpal Pharmaceuticals Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹268.72	₹208.70	₹236.71	₹217.58
Other Income	₹8.19	₹9.28	₹5.73	₹3.43
Total Revenue	₹276.91	₹217.98	₹242.45	₹221.01
Total Expenses	₹226.73	₹188.11	₹204.18	₹194.37
Profit Before Tax	₹69.86	₹29.87	₹34.81	₹26.64
Tax	₹14.50	₹7.41	₹8.09	₹7.79
Profit After Tax	₹55.36	₹22.46	₹26.72	₹18.86
EPS - Basic	₹8.26	₹3.40	₹10.20	₹7.20
EPS - Diluted	₹8.22	₹3.39	₹10.20	₹7.20

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹69.86	₹29.87	₹34.81	₹26.64
Income before WC changes	₹57.92	₹38.14	₹44.44	₹25.24
Change in Assets	-₹1.48	₹11.12	₹9.39	-₹8.62
Change in Liabilities	₹7.00	-₹5.58	₹0.10	-₹2.84
Change in WC	₹5.52	₹5.54	₹9.50	-₹11.46
Cash flow from Operations	₹55.30	₹35.17	₹46.66	₹6.91
Cash flow from Investing	-₹45.15	-₹24.55	-₹57.67	-₹25.78
Cash flow from Financing	-₹11.70	-₹8.91	-₹0.46	-₹17.55
Total Cash Flow	-₹1.55	₹1.71	-₹11.47	-₹36.42
Cash (Start of the year)	₹12.76	₹11.05	₹22.53	₹58.94
Cash (End of the year)	₹11.22	₹12.76	₹11.05	₹22.53

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹117.07	₹20.30	₹30.39	₹55.14
Current Assets	₹161.19	₹196.78	₹164.56	₹109.08
Total Assets	₹278.26	₹217.08	₹194.95	₹164.23
Current Liabilities	₹25.90	₹19.13	₹27.57	₹26.97
Net Current Asset	₹135.29	₹177.65	₹136.99	₹82.11
Non-Current Liabilities	₹12.41	₹10.55	₹8.49	₹4.49
Equity Capital	₹239.95	₹187.40	₹158.89	₹132.76
Total Equity & Liabilities	₹278.26	₹217.08	₹194.95	₹164.23

* All values are in INR Crore

Qty

Bid

Ask

Qty

221.61

Bid Total: 0

Ask Total: 10

Buy orders: 0%

Sell orders: 100%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Slightly Bullish

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

42.48

Neutral

ATR (14)

8.74

Neutral

STOCH(9,6)

8.77

Bullish

STOCH RSI (14)

Bullish

ADX(9)

19.09

Bullish

UO(9)

Neutral

ROC(12)

-8.76

Bearish

WillR(14)

-94.76

Bullish

Period

Simple value

Exponential vaue

221.43

221.2

10D

224.69

223.79

20D

229.24

224.53

50D

216.66

218.01

100D

203.28

209.57

About Jagsonpal Pharmaceuticals

ISIN

INE048B01035

Sector Market Cap

₹ 1,436.27 Cr

Jagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.

Jagsonpal Pharmaceuticals Financial Highlights

Revenue: Jagsonpal Pharmaceuticals reported revenue of ₹299.23 crore in FY26 vs ₹276.91 crore in FY25. It showed an increase of 8.06% on a yearly basis.
Operating Profit: Jagsonpal Pharmaceuticals reported an operating profit of ₹57.52 crore in FY26 vs ₹69.86 crore in FY25. It showed a decrease of 17.66% on a year-on-year basis.
Net Profit: Jagsonpal Pharmaceuticals reported a net profit of ₹43.08 crore in FY26 vs ₹55.36 crore in FY25. It showed a decrease of 22.18% on a yearly basis.

Jagsonpal Pharmaceuticals Quarterly Result Highlights

Jagsonpal Pharmaceuticals reported revenue of ₹67.37 crore in Mar 2026, compared with ₹75.93 crore in Dec 2025, representing a decrease of 11.27% on a quarter-on-quarter (QoQ) basis.
Jagsonpal Pharmaceuticals reported an operating profit of ₹11.76 crore in Mar 2026, compared with ₹14.52 crore in Dec 2025, representing a decrease of 19.01% on a quarter-on-quarter (QoQ) basis.
Jagsonpal Pharmaceuticals reported a profit of ₹8.76 crore in Mar 2026, compared with ₹10.95 crore in Dec 2025, reflecting a decrease of 20.00% on a QoQ basis.
The earnings per share (EPS) of Jagsonpal Pharmaceuticals stood at ₹8.26 during Mar 2026.